Keywords
TRPV-1 receptor
capsaicin.
Abstract
Nowadays differentiation between central and peripheral origin in Parkinson’s disease pain is considered as a clinical challenge. We present a long evolution Parkinson’s disease case of a 71 years old woman. Treatment undergone by the patient consists in deep brain stimulation (DBS), drugs dopamine agonist, monoamine oxidase inhibitor-B (MAO-B) and catechol-O-methyltransferase inhibitor (COMT).The patient was referred to the pain unit due to an outbreak of continuous pain in the upper outer region of the left knee and no response to pharmacological nocioceptive pain treatment. The patient was diagnosed with neuropathic pain after reviewing her clinical history, the physical examination and application of the DN4 scale. The chosen treatment was the application of a 179 mg capsaicin patch over the region where she was experiencing the pain and it resulted in an improvement from week one which still persisting twelve weeks later. Treatment with capsaicin patch was selected with the aim of avoid possible drugs interactions with her treatment. As a conclusion, the high topical concentration of capsaicin has been found to be effective and safe in a patient with complicated treatment (DBS plus usual treatment).References
1. Vila-Cha N, Cavaco S, Mendes A, Goncalves A, Moreira I, Fernandes J, et al. Unveiling the relationship between central parkinsonian pain and motor symptoms in Parkinson's disease. Eur J Pain. 2019;23(8):1475-85. DOI: 10.1002/ejp.1413
2. Raccagni C, Nonnekes J, Bloem BR, Peball M, Boehme C, Seppi K, et al. Gait and postural disorders in parkinsonism: a clinical approach. J Neurol [Internet]. 2019; [citado Nov 2019]. DOI: 10.1007/s00415-019-09382-1 doi: 10.1007/s00415-019-09382-1.
3. Marques A, Attal N, Bouhassira D, Moisset X, Cantagrel N, Rascol O, et al. How to diagnose parkinsonian central pain? Parkinsonism Relat Disord. 2019;64:50-3. DOI: 10.1016/j.parkreldis.2019.04.025.
4. Marrone MC, Morabito A, Giustizieri M, Chiurchiu V, Leuti A, Mattioli MC. TRPV1 channels are critical brain inflammation detectors and neuropathic pain biomarkers in mice. Nat Commun. 2017;8:a15292. DOI: 10.1038/ncomms15292.
5. Nam JH, Park ES, Won SY, Lee YA, Kim KI, Jeong JY, et al. TRPV1 on astrocytes rescues nigral dopamine neurons in Parkinson's disease via CNTF. Brain. 2015;138(Pt 12):3610-22. DOI: 10.1093/brain/awv297.
6. Yoshida A, Furube E, Mannari T, Takayama Y, Kittaka H, Tominaga M, et al. TRPV1 is crucial for proinflammatory STAT3 signaling and thermoregulation-associated pathways in the brain during inflammation. Sci Rep. 2016;6(1):26088. DOI: 10.1038/srep26088.
7. Chung YC, Baek JY, Kim SR, Ko HW, Bok E, Shin WH, et al. Capsaicin prevents degeneration of dopamine neurons by inhibiting glial activation and oxidative stress in the MPTP model of Parkinson's disease. Exp Mol Med. 2017;49(3):e298. DOI: 10.1038/emm.2016.159.
8. Perez C, Galvez R, Huelbes S, Insausti J, Bouhassira D, Diaz S, et al. Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component. Health Qual Life Outcomes. 2007;5:66. DOI: 10.1186/1477-7525-5-66.
9. Bouchenaki H, Bègou M, Magy L, Hajj R, Demiot C. Pharmacological management of neuropathic pain. Thèrapie. 2019;74(6):633-43. DOI: 10.1016/j.therap.2019.04.003.
10. Blair HA. Capsaicin 8% dermal patch: a review in peripheral neuropathic pain. Drugs. 2018;78(14):1489-500. DOI: 10.1007/s40265-018-0982-7.
11. Gustorff B, Poole C, Kloimstein H, Hacker N, Likar R. Treatment of neuropathic pain with the capsaicin 8% patch: Quantitative sensory testing (QST) in a prospective observational study identifies potential predictors of response to capsaicin 8% patch treatment. Scand J Pain. 2013;4(3):138-145. DOI: 10.1016/j.sjpain.2013.04.001.
12. Kurtis MM, Rajah T, Delgado LF, Dafsari HS. The effect of deep brain stimulation on the non-motor symptoms of Parkinson’s disease: a critical review of the current evidence. NPJ Parkinsons Dis. 2017;3:16024. DOI: 10.1038/npjparkd.2016.24.